A Glimpse into the Structural Properties of the Intermediate and Transition State in the Folding of Bromodomain 2 Domain 2 by Φ Value Analysis.
bromodomain
folding kinetics
mutagenesis
protein folding
protein stability
Φ value analysis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
31 May 2021
31 May 2021
Historique:
received:
03
05
2021
revised:
21
05
2021
accepted:
27
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
22
7
2021
Statut:
epublish
Résumé
Bromodomains (BRDs) are small protein interaction modules of about 110 amino acids that selectively recognize acetylated lysine in histones and other proteins. These domains have been identified in a variety of multi-domain proteins involved in transcriptional regulation or chromatin remodeling in eukaryotic cells. BRD inhibition is considered an attractive therapeutic approach in epigenetic disorders, particularly in oncology. Here, we present a Φ value analysis to investigate the folding pathway of the second domain of BRD2 (BRD2(2)). Using an extensive mutational analysis based on 25 site-directed mutants, we provide structural information on both the intermediate and late transition state of BRD2(2). The data reveal that the C-terminal region represents part of the initial folding nucleus, while the N-terminal region of the domain consolidates its structure only later in the folding process. Furthermore, only a small number of native-like interactions have been identified, suggesting the presence of a non-compact, partially folded state with scarce native-like characteristics. Taken together, these results indicate that, in BRD2(2), a hierarchical mechanism of protein folding can be described with non-native interactions that play a significant role in folding.
Identifiants
pubmed: 34073056
pii: ijms22115953
doi: 10.3390/ijms22115953
pmc: PMC8199192
pii:
doi:
Substances chimiques
Transcription Factors
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : 201744NR8S
Références
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):128-33
pubmed: 17179214
J Mol Biol. 1995 Nov 10;253(5):771-86
pubmed: 7473751
J Biol Chem. 2017 Oct 6;292(40):16734-16745
pubmed: 28798233
Science. 2012 Nov 23;338(6110):1042-6
pubmed: 23180855
Curr Opin Struct Biol. 2004 Feb;14(1):70-5
pubmed: 15102452
Acc Chem Res. 2021 Mar 2;54(5):1251-1259
pubmed: 33550810
Adv Protein Chem. 1970;24:1-95
pubmed: 4912353
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8302-7
pubmed: 26100906
Proc Natl Acad Sci U S A. 2004 May 25;101(21):7976-81
pubmed: 15150406
N Engl J Med. 2012 Aug 16;367(7):647-57
pubmed: 22894577
Protein Sci. 1994 Apr;3(4):650-68
pubmed: 8003983
Biochem Biophys Rep. 2017 Jul 08;11:99-104
pubmed: 28955774
Proc Natl Acad Sci U S A. 2020 Dec 11;:
pubmed: 33310900
Genes (Basel). 2012 May 29;3(2):320-43
pubmed: 24704920
J Chem Theory Comput. 2013 Sep 10;9(9):4225-32
pubmed: 26592411
Biochemistry. 1988 Oct 18;27(21):8063-8
pubmed: 3233195
Biophys Chem. 2007 Jul;128(2-3):105-13
pubmed: 17498862
J Med Chem. 2016 Feb 25;59(4):1340-9
pubmed: 26125948
Oncogene. 2007 Aug 13;26(37):5521-7
pubmed: 17694091
Expert Rev Mol Med. 2011 Sep 13;13:e29
pubmed: 21933453
J Mol Biol. 1992 Apr 5;224(3):805-18
pubmed: 1569558
Nat Struct Mol Biol. 2009 Mar;16(3):318-24
pubmed: 19252485
Anal Biochem. 1989 Nov 1;182(2):319-26
pubmed: 2610349
Biochem Pharmacol. 2016 Apr 15;106:1-18
pubmed: 26707800
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
PLoS One. 2016 Jul 12;11(7):e0159180
pubmed: 27403962
Structure. 2008 Apr;16(4):643-52
pubmed: 18400184